BDBM612772 US11725005, Compound 113

SMILES Cc1cc(-c2cncc(-c3ccnc(Nc4cc(NC(=O)c5ccc(CN6CCN(C)CC6)cc5)ccc4C)n3)c2)[nH]n1

InChI Key InChIKey=YMHOIAKNPORUIV-UHFFFAOYSA-N

Data  6 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 612772   

TargetMast/stem cell growth factor receptor Kit(Human)
Inhibikase Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 612772BDBM612772(US11725005, Compound 113)
Affinity DataIC50: 7.5nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl22 mM DTT) and Stop buffer (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Reag...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetMast/stem cell growth factor receptor Kit(Human)
Inhibikase Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 612772BDBM612772(US11725005, Compound 113)
Affinity DataIC50: 8.90nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl22 mM DTT) and Stop buffer (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Reag...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetTyrosine-protein kinase ABL1(Human)
Inhibikase Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 612772BDBM612772(US11725005, Compound 113)
Affinity DataIC50: 35nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl22 mM DTT) and Stop buffer (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Reag...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetTyrosine-protein kinase ABL2(Human)
Inhibikase Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 612772BDBM612772(US11725005, Compound 113)
Affinity DataIC50: 50.1nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl22 mM DTT) and Stop buffer (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Reag...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetTyrosine-protein kinase ABL1(Human)
Inhibikase Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 612772BDBM612772(US11725005, Compound 113)
Affinity DataIC50: 108nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl22 mM DTT) and Stop buffer (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Reag...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetTyrosine-protein kinase ABL2(Human)
Inhibikase Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 612772BDBM612772(US11725005, Compound 113)
Affinity DataIC50: 203nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl22 mM DTT) and Stop buffer (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Reag...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent